G2 Intelligence

?? Stay informed. Stay ahead. G2 Intelligence Reports provide the critical insights you need into the evolving clinical diagnostics landscape. From regulatory changes and market trends to emerging technologies—equip yourself with the clarity and confidence to make strategic decisions. Explore the latest reports today ?? https://bit.ly/3EAk9d4

LabX Media Group has acquired The Dark Intelligence Group, a major development in the world of clinical lab intelligence. As part of the LMG family, G2 Intelligence is excited for what this means for the future of lab insights, industry analysis, and expert reporting. Stay tuned for more updates!

?? Bird flu testing is getting a major boost! ?? Labcorp, Quest, and ARUP are teaming up with the CDC to develop new tests—because when it comes to potential outbreaks, labs are on the frontlines. If bird flu spreads, are our testing capabilities ready to soar… or will they be playing catch-up? Check out Ron Shinkman’s article on G2 Intelligence for the inside scoop! ?? https://bit.ly/3DP5xXc

?? Did you know? A recent False Claims Act (FCA) ruling could have major consequences for labs. ????? But what does it really mean for compliance, billing, and risk management? Rachel (Muenz) Vachon breaks it all down in this must-read article on G2 Intelligence. ?? https://bit.ly/3Fqno7a ?? Drop your thoughts in the comments—how do you see this decision impacting the industry?

?? On-Demand Testing: A Lab Director’s Perspective ?? How can clinical labs implement accessible, on-demand testing while maintaining quality and efficiency? Christina P. Nickel, MHA, MLS(ASCP)CM, CPHQ, shares firsthand insights on the challenges, successes, and key takeaways from real-world implementation. ?? Read the full article here:?https://bit.ly/41Dd96U

Advancing Sepsis Detection: MeMed ’s Breakthrough Device Designation Early and accurate sepsis detection is critical for improving patient outcomes. MeMed’s Sepsis Test has just received Breakthrough Device designation, highlighting its potential to enhance rapid diagnosis and clinical decision-making. ?? Read Ron Shinkman’s article on G2 Intelligence to explore what this means for the future of sepsis diagnostics: https://bit.ly/4imQWkZ

Is your lab keeping up—or falling behind? Regulations shift, trends evolve, and staying ahead takes more than guesswork. G2 Intelligence’s Lab Industry Advisory subscriptions give you expert insights, compliance updates, and strategic guidance—delivered straight to you. Make smarter decisions with confidence. ?? Explore your options: https://bit.ly/4djHUlq

?? Ever wondered if your lab is getting a fair deal on in-network rates? XiFin, Inc.’s Payor Rate Transparency Monitor is here to pull back the curtain. Think of it like checking the price tag before committing—because why should labs settle for mystery pricing? Scott Wallask breaks it all down in this must-read! ?? Read more: https://bit.ly/4kkzoqT

?? Genetic counselors play a crucial role in clinical labs, guiding patients and providers through complex results—but when it comes to reimbursement, they’re often left out of the equation. ??? Michael Schubert explores the shifting policies that could change that. Will expertise finally get the financial recognition it deserves? ?? Read more:?https://bit.ly/3QKQQqN

In a world where every brand is competing for attention, how do you make sure yours is heard by the right people? At G2 Intelligence, we don’t just deliver content—we connect decision-makers with the insights, innovations, and solutions shaping the future of diagnostics and lab operations. If your brand has something to say, why not say it where it matters? Discover how strategic advertising with G2 Intelligence can put you in front of the audience that counts. ?? Learn more: https://bit.ly/4hqK3hn